| 产品名称 |
点击数 |
| Anti-Human VIM/Vimentin Recombinant Antibody , PE|抗人VIM/波形蛋白重组抗体，PE标记(靶标：波形蛋白) |
476 |
| Anti-Human KRT19/CK19 Recombinant Antibody , PE|抗人KRT19/CK19重组抗体，PE标记(靶标：角蛋白19/细胞角蛋白19) |
342 |
| Anti-Human CD126/IL6R/IL-6RA Recombinant Antibody , PE|抗人CD126/IL6R/IL-6RA重组抗体，PE标记(靶标：白细胞介素6受体/CD126) |
368 |
| Anti-Human CD126/IL6R/IL-6RA Recombinant Antibody , PE|抗人CD126/IL6R/IL-6RA重组抗体，PE标记(靶标：白细胞介素6受体/CD126) |
351 |
| Anti-Human CD63/LAMP3 Recombinant Antibody, PE|抗人CD63/LAMP3重组抗体，PE标记(靶标：溶酶体相关膜蛋白3/CD63) |
375 |
| Anti-Human CD63/LAMP3 Recombinant Antibody , PE|抗人CD63/LAMP3重组抗体，PE标记(靶标：溶酶体相关膜蛋白3/CD63) |
475 |
| Anti-Human FGF2/bFGF Recombinant Antibody , PE|抗人FGF2/bFGF重组抗体，PE标记(靶标：成纤维细胞生长因子2/碱性成纤维细胞生长因子) |
489 |
| Anti-Human CD48 Recombinant Antibody , PE|抗人CD48重组抗体，PE标记(靶标：CD48分子) |
205 |
| Anti-Human CD48 Recombinant Antibody, PE|抗人CD48重组抗体，PE标记(靶标：CD48分子) |
524 |
| Anti-Human CXCL1/NAP-3/GRO-alpha Recombinant Antibody , PE|抗人CXCL1/NAP-3/GRO-α重组抗体，PE标记(靶标：CXC趋化因子配体1/中性粒细胞活化肽-3/生长调节癌基因α) |
239 |
| Anti-Human CD7 Recombinant Antibody, PE|抗人CD7重组抗体，PE标记(靶标：CD7分子) |
259 |
| Anti-Human CD7 Recombinant Antibody, PE|抗人CD7重组抗体，PE标记(靶标：CD7分子) |
227 |
| Anti-Human CSF1/M-CSF Recombinant Antibody , PE|抗人CSF1/M-CSF重组抗体，PE标记(靶标：集落刺激因子1/巨噬细胞集落刺激因子) |
305 |
| Anti-Human CD140b/PDGFRB Recombinant Antibody , PE|抗人CD140b/PDGFRB重组抗体，PE标记(靶标：血小板衍生生长因子受体β/CD140b) |
244 |
| Anti-Human CD140b/PDGFRB Recombinant Antibody, PE|抗人CD140b/PDGFRB重组抗体，PE标记(靶标：血小板衍生生长因子受体β/CD140b) |
492 |
| Anti-Human TACSTD2/TROP2 Recombinant Antibody , PE|抗人TACSTD2/TROP2重组抗体，PE标记(靶标：肿瘤相关钙信号转导蛋白2/TROP2) |
447 |
| Anti-Human TACSTD2/TROP2 Recombinant Antibody, PE|抗人TACSTD2/TROP2重组抗体，PE标记(靶标：肿瘤相关钙信号转导蛋白2/TROP2) |
406 |
| Anti-Human C1S Recombinant Antibody , PE|抗人C1S重组抗体，PE标记(靶标：补体C1s亚基) |
533 |
| Anti-Human CSF3/G-CSF Recombinant Antibody , PE|抗人CSF3/G-CSF重组抗体，PE标记(靶标：集落刺激因子3/粒细胞集落刺激因子) |
509 |
| Anti-Human GZMB Recombinant Antibody, PE|抗人GZMB重组抗体，PE标记(靶标：颗粒酶B) |
338 |
